Jerome D. Jabbour
2014
In 2014, Jerome D. Jabbour earned a total compensation of $573.8K as President at Matinas BioPharma Holdings.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Option Awards | $268,813 |
| Salary | $275,000 |
| Total | $573,813 |
Jabbour received $275K in salary, accounting for 48% of the total pay in 2014.
Jabbour also received $30K in bonus and $268.8K in option awards.
Rankings
In 2014, Jerome D. Jabbour's compensation ranked 9,821st out of 13,032 executives tracked by ExecPay. In other words, Jabbour earned more than 24.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,821 out of 13,032 | 25th |
Division Manufacturing | 3,721 out of 4,965 | 25th |
Major group Chemicals And Allied Products | 1,273 out of 1,690 | 25th |
Industry group Drugs | 1,013 out of 1,369 | 26th |
Industry Pharmaceutical Preparations | 776 out of 1,042 | 26th |
Source: SEC filing on September 22, 2016.
Jabbour's colleagues
We found two more compensation records of executives who worked with Jerome D. Jabbour at Matinas BioPharma Holdings in 2014.
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019